What is Oruka Therapeutics, Inc.'s granted (in shares)?

Oruka Therapeutics, Inc. (ORKA) reported granted (in shares) of 1.5M in Q1 2026.

How has Oruka Therapeutics, Inc.'s granted (in shares) changed year-over-year?

Oruka Therapeutics, Inc.'s granted (in shares) decreased by 12.6% year-over-year, from 1.7M to 1.5M.

What does granted (in shares) mean?

The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.

Oruka Therapeutics, Inc. ORKA Granted (in shares)

Granted (in shares) at other companies

CHE

ChemedCHE

$110.38K+38.8%

The Hanover Insurance GroupTHG

148.1K+5.5%

GenpactG

0—

Ondas, Inc. ONDS

7.4M+45.6%

FTI ConsultingFCN

0—

RenasantRNST

0—

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s granted (in shares)?: Oruka Therapeutics, Inc. (ORKA) reported granted (in shares) of 1.5M in Q1 2026.
How has Oruka Therapeutics, Inc.'s granted (in shares) changed year-over-year?: Oruka Therapeutics, Inc.'s granted (in shares) decreased by 12.6% year-over-year, from 1.7M to 1.5M.
What does granted (in shares) mean?: The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.